Tech earnings reactions, Starbucks' growth plan, Apple's flat growth, Shopify's success. Huge earnings reactions from DoorDash and Roku. United Auto Workers' negotiations with automakers. Stocks on radar: WK Kellogg and Quest Diagnostics.
Read more
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
The United Auto Workers' Union reached tentative agreements with automakers Ford, GM, and Stellantis, securing significant gains for its members, including pay raises and improved family leave policies.
Kellogg aims to leverage its top-selling cereal brands like Frosted Flakes and Rice Krispies to overcome challenges in the face of declining cereal consumption and win over health-conscious consumers.
Deep dives
The UAW strikes deals with automakers
The United Auto Workers' Union reached tentative deals with Ford, GM, and Stellantis, securing significant gains for its members. The agreements include pay raises, the return of cost-of-living adjustments, and improved family leave policies. The UAW also secured better terms for new plants, including joint venture battery plants. While the automakers did not achieve major wins, they avoided agreeing to certain demands such as defined benefit pensions for new workers. Ratification by union members is now awaited for the deals to be finalized.
Kellogg's prospects and challenges
Kellogg (KLG) is the second-largest seller of ready-to-eat cereal in the US and is known for popular brands like Frosted Flakes, Rice Krispies, and Fruit Loops. The company faces competition from healthier food options, leading to some weakness in their sales. However, Kellogg's recently spun off from its parent company and aims to leverage its top-selling brands to overcome challenges. While prospects for the company are uncertain due to declining cereal consumption, the opportunity may lie in winning over health-conscious consumers.
Quest Diagnostics resilient in non-COVID testing
Quest Diagnostics, a leading diagnostics and blood testing company, operates as a duopoly with LabCorp. While their COVID-19 testing revenue dropped significantly due to lower demand, their base testing business has shown resilience. Non-COVID testing volumes increased nearly 6% in the last quarter, surpassing expectations. The company continues to raise its full-year guidance, expecting earnings per share between $8.65 and $8.75. Quest Diagnostics generates substantial free cash flow, allowing for potential acquisitions, dividends, and share buybacks.